Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SurgePays (SURG) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for SurgePays (SURG) over the last 17 years, with Q3 2025 value amounting to $2.5 million.

  • SurgePays' Cash & Equivalents fell 8157.82% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year decrease of 8157.82%. This contributed to the annual value of $11.8 million for FY2024, which is 1936.57% down from last year.
  • According to the latest figures from Q3 2025, SurgePays' Cash & Equivalents is $2.5 million, which was down 8157.82% from $4.4 million recorded in Q2 2025.
  • Over the past 5 years, SurgePays' Cash & Equivalents peaked at $42.9 million during Q1 2024, and registered a low of $574824.0 during Q2 2021.
  • For the 5-year period, SurgePays' Cash & Equivalents averaged around $10.4 million, with its median value being $7.0 million (2022).
  • As far as peak fluctuations go, SurgePays' Cash & Equivalents soared by 141429.41% in 2022, and later crashed by 8854.04% in 2025.
  • SurgePays' Cash & Equivalents (Quarter) stood at $6.3 million in 2021, then grew by 11.97% to $7.0 million in 2022, then surged by 107.83% to $14.6 million in 2023, then dropped by 19.37% to $11.8 million in 2024, then tumbled by 78.67% to $2.5 million in 2025.
  • Its last three reported values are $2.5 million in Q3 2025, $4.4 million for Q2 2025, and $5.4 million during Q1 2025.